Fenggang Hou
Overview
Explore the profile of Fenggang Hou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jia J, Yang Y, Shi C, Du M, Tang Y, Yin X, et al.
Altern Ther Health Med
. 2024 Mar;
31(1):134-142.
PMID: 38551443
Objective: To observe the effect of oral Quma Tongluo decoction on oxaliplatin-related chronic peripheral neuropathy. Methods: A total of 64 patients who met the inclusion criteria were randomly divided into...
2.
Wang Y, Zhu T, Shi Q, Zhu G, Zhu S, Hou F
J Immunother Cancer
. 2024 Jan;
12(1).
PMID: 38242718
Tumor-draining lymph nodes (TDLNs) are potential immunotherapy targets that could expand the population of patients with colorectal cancer (CRC) who may benefit from immunotherapy. Currently, pathological detection of tumor cell...
3.
Wang Y, Lin W, Huang G, Nie S, Yu Q, Hou F, et al.
J Ethnopharmacol
. 2023 Aug;
319(Pt 1):117072.
PMID: 37625603
Ethnopharmacological Relevance: Transcatheter arterial chemoembolization (TACE) is recommended as the first-line therapy for unresected primary liver cancer (PLC), but only partial patients could benefit from TACE due to the serious...
4.
Duan Y, Huo J, Chen M, Hou F, Yan G, Li S, et al.
Appl Intell (Dordr)
. 2023 Jan;
:1-17.
PMID: 36685641
Sepsis is a life-threatening medical condition that is characterized by the dysregulated immune system response to infections, having both high morbidity and mortality rates. Early prediction of sepsis is critical...
5.
Tang Y, Zong S, Zeng H, Ruan X, Yao L, Han S, et al.
Cancer Cell Int
. 2021 Apr;
21(1):221.
PMID: 33865381
MicroRNAs (miRNAs) are a class of small noncoding RNA molecules containing only 20-22 nucleotides. MiRNAs play a role in gene silencing and translation suppression by targeting and binding to mRNA....
6.
Zong S, Tang Y, Li W, Han S, Shi Q, Ruan X, et al.
Front Pharmacol
. 2020 Jun;
11:705.
PMID: 32499699
Various malignant tumors, including colorectal cancer, have the ability to form functional blood vessels for tumor growth and metastasis. Vasculogenic mimicry (VM) refers to the ability of highly invasive tumor...
7.
Han S, Huang T, Hou F, Yao L, Wang X, Wu X
Ther Adv Med Oncol
. 2019 Oct;
11:1758835919875851.
PMID: 31579115
Background: Expression of hypoxia-inducible factors (HIFs) has been observed, but their prognostic role in advanced cancers remains uncertain. We conducted a meta-analysis to establish the prognostic effect of HIFs and...
8.
Han S, Huang T, Wu X, Wang X, Li W, Liu S, et al.
Ther Adv Med Oncol
. 2019 Mar;
11:1758835919830831.
PMID: 30833990
Background: Novel prognostic markers and therapeutic targets for advanced cancer are urgently needed. This report with trial sequential analysis (TSA) was first conducted to provide robust estimates of the correlation...
9.
Han S, Huang T, Li W, Wang X, Wu X, Liu S, et al.
Front Oncol
. 2019 Feb;
9:39.
PMID: 30788285
Cancer stem cell marker CD44 and its variant isoforms (CD44v) may be correlated with tumor growth, metastasis, and chemo-radiotherapy resistance. However, the prognostic power of CD44 and CD44v in advanced...
10.
Han S, Huang T, Wu X, Wang X, Liu S, Yang W, et al.
J Oncol
. 2019 Jan;
2019:3905817.
PMID: 30693028
Background: The prognostic value of CD133 and SOX2 expression in advanced cancer remains unclear. This study was first conducted to investigate the association between CD133 or SOX2 positivity and clinical...